PCR-based Sanger sequencing showed KRAS mutations in metastatic tumor tissue of patients 2 (G12D), 3 (G12A) and 4 (G13D) and a NRAS mutation for patient 8 (G13R “c37G > C). This evidence concerns the gene NRAS and metastatic neoplasm.